These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37720045)

  • 1. Interventions for promoting patients' adherence to 14-day primaquine treatment in a highly malaria-endemic township in Myanmar: A qualitative study among key stakeholders.
    Win KM; Aung PL; Ring Z; Linn NYY; Kyaw MP; Nguitragool W; Cui L; Sattabongkot J; Lawpoolsri S
    Res Sq; 2023 Sep; ():. PubMed ID: 37720045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for promoting patients' adherence to 14-day primaquine treatment in a highly malaria-endemic township in Myanmar: a qualitative study among key stakeholders.
    Win KM; Aung PL; Ring Z; Linn NYY; Kyaw MP; Nguitragool W; Cui L; Sattabongkot J; Lawpoolsri S
    Malar J; 2023 Oct; 22(1):302. PubMed ID: 37814267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acceptability of targeted mass treatment with primaquine for local elimination of vivax malaria in a northern Myanmar township: a mixed-methods study.
    Aung PL; Soe MT; Soe TN; Oo TL; Aung PP; Khin A; Thi A; Phuanukoonnon S; Okanurak K; Cui L; Kyaw MP; Parker DM
    Parasit Vectors; 2021 Oct; 14(1):549. PubMed ID: 34689796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
    Takeuchi R; Lawpoolsri S; Imwong M; Kobayashi J; Kaewkungwal J; Pukrittayakamee S; Puangsa-art S; Thanyavanich N; Maneeboonyang W; Day NP; Singhasivanon P
    Malar J; 2010 Nov; 9():308. PubMed ID: 21040545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
    Milligan R; Daher A; Graves PM
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community acceptability, participation, and adherence to mass drug administration with primaquine for Plasmodium vivax elimination in Southern Thailand: a mixed methods approach.
    Saita S; Roobsoong W; Khammaneechan P; Sukchan P; Lawpoolsri S; Sattabongkot J; Cui L; Okanurak K; Phuanukoonnon S; Parker DM
    Malar J; 2023 Jan; 22(1):17. PubMed ID: 36635642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders.
    Adhikari B; Awab GR; von Seidlein L
    Malar J; 2021 Mar; 20(1):164. PubMed ID: 33757538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primaquine treatment and relapse in Plasmodium vivax malaria.
    Rishikesh K; Saravu K
    Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review.
    Drysdale M; Tan L; Martin A; Fuhrer IB; Duparc S; Sharma H
    Infect Dis Ther; 2023 Jan; 12(1):33-51. PubMed ID: 36378465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
    Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
    PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
    Galappaththy GN; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervised administration of primaquine may enhance adherence to radical cure for
    Rahi M; Sirohi PR; Sharma A
    Lancet Reg Health Southeast Asia; 2023 Jun; 13():100199. PubMed ID: 37383547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trial.
    Liu H; Xu JW; Deng DW; Yaw B; Nbwi HS; Wei C; Zhou XW; Li JX
    Parasit Vectors; 2024 Jan; 17(1):28. PubMed ID: 38254128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
    Thriemer K; Degaga TS; Christian M; Alam MS; Rajasekhar M; Ley B; Hossain MS; Kibria MG; Tego TT; Abate DT; Weston S; Mnjala H; Rumaseb A; Satyagraha AW; Sadhewa A; Panggalo LV; Ekawati LL; Lee G; Anose RT; Kiros FG; Simpson JA; Karahalios A; Woyessa A; Baird JK; Sutanto I; Hailu A; Price RN
    Lancet; 2023 Dec; 402(10417):2101-2110. PubMed ID: 37979594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial.
    Poespoprodjo JR; Burdam FH; Candrawati F; Ley B; Meagher N; Kenangalem E; Indrawanti R; Trianty L; Thriemer K; Price DJ; Simpson JA; Price RN
    Lancet Infect Dis; 2022 Mar; 22(3):367-376. PubMed ID: 34710363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers in distribution, ownership and utilization of insecticide-treated mosquito nets among migrant population in Myanmar, 2016: a mixed methods study.
    Linn SY; Maung TM; Tripathy JP; Shewade HD; Oo SM; Linn Z; Thi A
    Malar J; 2019 May; 18(1):172. PubMed ID: 31088451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
    Robinson LJ; Wampfler R; Betuela I; Karl S; White MT; Li Wai Suen CS; Hofmann NE; Kinboro B; Waltmann A; Brewster J; Lorry L; Tarongka N; Samol L; Silkey M; Bassat Q; Siba PM; Schofield L; Felger I; Mueller I
    PLoS Med; 2015 Oct; 12(10):e1001891. PubMed ID: 26505753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.